Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Lucy Bizien et al.|Science Immunology|2021Cited by 638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Proceedings of the National Academy of Sciences|2022Cited by 198
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 PneumoniaMartti Vanker, Karita Särekannu, Arnaud Fekkar et al.|Journal of Interferon & Cytokine Research|2023Cited by 30
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Research Square|2022Cited by 24
Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Adrian Gervais et al.|Science Immunology|2021Cited by 1